Ceribell (CBLL) Share-based Compensation (2023 - 2026)
Ceribell (CBLL) posted Share-based Compensation of $3.7 million for Q1 2026, up 10.84% on a QoQ basis from $3.4 million in Q4 2025, and up 58.56% year-over-year from $2.3 million in Q1 2025.
Ceribell (CBLL) Share-based Compensation (2023 - 2026) Analysis & Trends
Ceribell's Share-based Compensation history runs 4 years deep, the most recent figure standing at $3.7 million for Q1 2026.
- Quarterly Share-based Compensation rose 58.56% year-over-year to $3.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.6 million (up 44.15% YoY) and the FY2025 annual result came in at $12.2 million, up 125.89% from the prior year.
- Share-based Compensation was $3.7 million for Q1 2026 at Ceribell, up from $3.4 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $4.6 million in Q4 2024 and bottomed at $637000.0 in Q3 2023.
- A 4-year average of $2.3 million and a median of $2.3 million in 2025 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2024 — Share-based Compensation jumped 521.88% — and 2025, when it slipped 27.5%.
- Ceribell's Share-based Compensation stood at $745000.0 in 2023, then soared by 521.88% to $4.6 million in 2024, then declined by 27.5% to $3.4 million in 2025, then climbed by 10.84% to $3.7 million in 2026.
- Business Quant data shows CBLL's Share-based Compensation at $3.7 million in Q1 2026, $3.4 million in Q4 2025, and $3.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Ceribell | 613.16 Mn | 471.97 Mn | 23.12 Mn | 3.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.72 Mn |
| Mar 31, 2026 | 3.72 Mn |
| Dec 31, 2025 | 3.36 Mn |
| Dec 31, 2025 | 3.36 Mn |
| Sep 30, 2025 | 3.35 Mn |
| Sep 30, 2025 | 3.35 Mn |
| Jun 30, 2025 | 3.17 Mn |
| Jun 30, 2025 | 3.17 Mn |
| Mar 31, 2025 | 2.35 Mn |
| Mar 31, 2025 | 2.35 Mn |
| Dec 31, 2024 | 4.63 Mn |
| Dec 31, 2024 | 4.63 Mn |
| Sep 30, 2024 | 1.38 Mn |
| Sep 30, 2024 | 1.38 Mn |
| Jun 30, 2024 | 1.08 Mn |
| Jun 30, 2024 | 1.08 Mn |
| Mar 31, 2024 | 757,000.00 |
| Mar 31, 2024 | 757,000.00 |
| Dec 31, 2023 | 745,000.00 |
| Dec 31, 2023 | 745,000.00 |